- University News Archive - UA Little Rock /news-archive/tag/alex-biris/ UA Little Rock Wed, 20 Nov 2019 15:35:48 +0000 en-US hourly 1 https://wordpress.org/?v=7.1.4 UA Little Rock announces $750,000 grant for bone regeneration technology during Sen. Boozman’s visit to review research innovations /news-archive/2019/11/20/ua-little-rock-announces-750000-grant-for-bone-regeneration-technology-during-sen-boozmans-visit-to-review-research-innovations/ Wed, 20 Nov 2019 15:35:48 +0000 /news/?p=75774 ... UA Little Rock announces $750,000 grant for bone regeneration technology during Sen. Boozman’s visit to review research innovations]]> The 91¸£Àû´óÈ« announced a $750,000 grant from the U.S. Department of Defense to support the development of potentially life-saving bone regeneration technology during a Nov. 15 visit from Sen. John Boozman. The visit celebrated on-campus research initiatives that the senator championed for federal support.Ìý Pioneered at the UA Little Rock Center for Integrative Nanotechnology Sciences, the NuCressâ„¢ scaffold is a multifunctional device designed to promote controlled, robust bone regeneration in fractures, gaps where bone is missing, and major injury defects, including previously untreatable catastrophic injuries. Such a technology is highly needed by a wide variety of patients, including wounded soldiers, victims of major accidents and trauma, and those with various bone diseases. The $750,000 grant, provided by the Department of Defense’s Peer Reviewed Orthopaedic Research Program, will investigate the scaffold’s ability to combat infection while regenerating bone. Earlier this fall, UA Little Rock received a $5.6 million grant from the Department of Defense to fund the pre-market development of the same bone regeneration technology. Sen. Boozman supported both grants during the application stages.Ìý “The commitment by DOD to continue advancing bone regeneration technology demonstrates the importance of this research and the opportunities it presents for our wounded warriors,â€� Sen. Boozman said. “I’m proud to support this award so we can discover breakthroughs, spark innovation, and achieve things we might have thought were impossible. This and other important research being conducted at UA Little Rock is essential to moving us forward and gives Arkansas something to be very proud of.â€� During the visit to UA Little Rock’s nanotechnology center, Sen. Boozman met with faculty and student researchers and toured the labs in which the NuCressâ„¢ scaffoldÌý materials are developed. The bone regeneration research is led by researchers at UA Little Rock (principal investigator Dr. Alexandru Biris), the University of Arkansas for Medical Sciences (principal investigator Dr. Mark Smeltzer), and the University of Tennessee, Knoxville (principal investigator Dr. David Anderson).
Sen. John Boozman and member of his staff visit with the researchers at UA Little Rock's Center for Integrative Nanotechnology Sciences.

Sen. John Boozman and members of his staff visit with the researchers at UA Little Rock’s Center for Integrative Nanotechnology Sciences.

“We are honored by both the DOD’s and Sen. Boozman’s continued support of our research,â€� Biris said. “Without it, we could not continue to develop this potentially life-changing technology.â€� The NuCressâ„¢ bone regeneration scaffold also recently received a TechConnect Defense Innovation award for the second consecutive year. Judged by a team of military and industry experts, the award is given to the top 15 percent of submissions to the annual Defense TechConnect Summit and Expo. Award selections are based on the potential positive impact the technology will have for the military and national security. The award was presented to NuShores Biosciences LLC, the licensee of the NuCressâ„¢ scaffold.Ìý “The recognition of our NuCressâ„¢ technologies by the Expo judges is gratifying and much appreciated,â€� NuShores CEO Sharon Ballard said. “This year’s conference validated the marketplace need for our initial orthopedic product and for applying our NuCressâ„¢ technologies to new medical indications.â€� Additionally, Sen. Boozman met with Dr. Nitin Agarwal, Jerry L. Maulden-Entergy endowed chair and distinguished professor of information science, who received a $2.4 million grant from the Department of Defense earlier this year to develop ways to track emerging cyber-social threats and strengthen social cybersecurity research infrastructure. Sen. Boozman also supported this effort. Agarwal updated Sen. Boozman on how technology being developed at UA Little Rock in the Collaboratorium for Social Media and Online Behavioral Studies (COSMOS) has been used to track malicious activities, including the dissemination of propaganda, hoaxes, and disinformation to influence beliefs and behaviors. These technologies include Blogtrackers and YouTubeTracker.
Sen. John Boozman, his staff, and UA Little Rock members hear a research update from Dr. Nitin Agarwal.

Sen. John Boozman, his staff, and UA Little Rock members hear a research update from Dr. Nitin Agarwal.

In this most recent grant, Agarwal will develop research infrastructure to assess social media, specifically blogs and YouTube, in real time and respond to the growing weaponization of online discourse in influencing peacekeeping, and tactical, operational, and strategic operations. The research infrastructure will include development of models, software applications, and training programs. Military units at all levels will benefit from the intended goals of the project in identification of threats and opportunities within the information environment. “We are thankful to Senator John Boozman for supporting the social networking research at UA Little Rock,â€� Agarwal said. “The senator recognizes the importance of developing new approaches, software tools, and training programs for national security in cyberspace, and this grant was enabled through his support of funding for the Navy’s Social Networks Analysis program.â€� The U.S. Army Medical Research Acquisition Activity, 839 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work is supported by the Department of Defense, through the Joint Warfighter Medical Research Program under Award No. W81XWH1920014 and through the Peer Reviewed Orthopaedic Research Program under Award No. W81XWH1910742.Ìý Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. ]]>
U.S. Department of Defense awards UA Little Rock $5.6 million grant to develop bone regeneration technology /news-archive/2019/10/24/bone-regeneration-dod-grant/ Thu, 24 Oct 2019 14:52:39 +0000 /news/?p=75524 ... U.S. Department of Defense awards UA Little Rock $5.6 million grant to develop bone regeneration technology]]> The U.S. Department of Defense (DOD) has awarded the 91¸£Àû´óÈ« a $5.6 million grant to advance the NuCressâ„¢ scaffold, a groundbreaking bone regeneration technology.

The grant brings together an interdisciplinary team from UA Little Rock, led by principal investigator Dr. Alex Biris; the University of Tennessee, Knoxville, led by Dr. David Anderson; and the University of Arkansas for Medical Sciences (UAMS), led by Dr. Mark Smeltzer.

Biris and Anderson have worked together since 2006 to develop this pioneering medical device. The NuCress™ scaffold is in the final stages of moving from the laboratory to the surgical theater, with potential future uses in both military and civilian hospitals. The new award from the DOD’s Joint Warfighter Medical Research Program will help facilitate this transition by funding critical go-to-market research.

U.S. Sen. John Boozman, who supported the UA Little Rock proposal to the DOD and was instrumental in securing federal funding for the project’s earlier research, congratulated the team on the award.

“Bone regeneration technology is so important to the recovery of our warfighters from severe injuries,� Boozman said. “UA Little Rock and its partners have made tremendous progress taking this novel nanotechnology solution from the laboratory to the point of clinical trials.�

The NuCressâ„¢ scaffold is an implantable device that promotes controlled, robust bone regeneration in fractures, gaps where bone is missing, and major injury defects, including previously untreatable catastrophic injuries. The device degrades as the bone regenerates, potentially eliminating the need for multiple surgeries-a major source of complications in current bone gap treatments.

“I’m thrilled to see over a decade of collaborative work result in this continued DOD support, and I look forward to seeing it develop into a clinically beneficial product,â€� said Biris, director of the UA Little Rock Center for Integrative Nanotechnology Sciences.

Related Story: UA Little Rock researchers pioneer device to speed bone regeneration

Such a device is in high demand by a wide variety of people, including wounded soldiers, victims of major accidents and trauma, and patients with bone disease.

“The NuCress™ scaffold is a game-changing technology that will revolutionize treatment of bone diseases because it is capable of simultaneously promoting bone regeneration and delivering antibiotics, growth factors, and cell-based therapies,� Anderson said.

UA Little Rock Chancellor Christina Drale said the grant will help the Center for Integrative Nanotechnology Sciences fulfill its mission to accelerate world-class innovations in nanotechnology into practical applications that will benefit society.

“This new funding from the Department of Defense will help our research team fulfill that mission in this particularly exciting area of nanotechnology for medical applications,� Drale said.

Studies funded by past DOD awards proved the scaffold’s versatility and ability to regenerate large, missing segments of bone. The new, four-year DOD award will support pre-market work, including manufacturing and U.S. Food and Drug Administration clearance. If successful, the project will allow the scaffold to move toward clinical trials, validate its utility for clinicians, and develop a new market application for treating infection.

Smeltzer, the research team’s infection expert, looks forward to this new market potential.

“Infection is a dreaded complication of traumatic bone injury, and the ability to incorporate antibiotics into the NuCress™ scaffold offers the tremendous added benefit of preventing infection in a contaminated bone defect without compromising its bone regenerative properties,� Smeltzer said.

The U.S. Army Medical Research Acquisition Activity, 839 Chandler Street, Fort Detrick, MD 21702-5014 is the awarding and administering acquisition office. This work is supported by the Department of Defense, through the Joint Warfighter Medical Research Program under Award No. W81XWH1920014. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.

]]>
UA Little Rock employees ride Tour de Rock in honor of vice chancellor’s brother /news-archive/2019/06/21/tour-de-rock/ Fri, 21 Jun 2019 15:32:11 +0000 /news/?p=74583 ... UA Little Rock employees ride Tour de Rock in honor of vice chancellor’s brother]]> Nine employees from the 91¸£Àû´óÈ« rode nearly 550 miles in honor of a vice chancellor’s brother who is battling cancer.Ìý Steve McClellan, UA Little Rock vice chancellor for finance and administration, sponsored the employees to ride the on June 1 in honor of his brother, Bruce McClellan, who is battling lung cancer. CARTI’s 16th annual Tour de Rock supports CARTI’s continued fight against cancer by providing the most advanced forms of treatment available while also meeting the needs of patients and their families. Nearly 1,000 cyclists rode one of four routes of 25, 50, 62, or 100 miles. This is the second year that McClellan has sponsored a team of UA Little Rock cyclists to ride the Tour de Rock and raise money for cancer. Last year, the UA Little Rock team rode nearly 500 miles in honor of Bruce McClellan. “One of the most touching things about the event is that you get to write the name of a person who is fighting cancer on your shirt,â€� said Martial Trigeaud, business consultant with the Arkansas Small Business and Technology Development Center and faculty advisor of the UA Little Rock Cycling Club. “This year, we wrote the name of Steve’s brother, Bruce. Many people also wrote the name of another friend or relative, someone they love, who has faced cancer.â€� UA Little Rock employees and students who rode in the Tour de Rock include Alex Biris, director of the Center for Integrative Nanotechnology Sciences; Thomas Bunton, associate vice chancellor and chief information officer; Molly Castner, deputy athletic director and senior woman administrator; Emilie Darrigues, a Ph.D. student of applied science; John Evans, senior associate athletic director for facilities and events; Ian Hadden, director of energy management services; Ashton Hale, a criminal justice graduate student; Sean Orme, a Ph.D. student in computer science; and Trigeaud. One of UA Little Rock’s riders, Hadden, even took on the special challenge of riding in the pace group, where cyclists complete 100 miles in under 5 hours. Hadden finished 100 miles in 4:54:03 and burned 8,680 calories in that time.  
Faculty, staff, and students from UA Little Rock ride the Tour de Rock in honor of Steve McClellan's brother, Bruce.

Faculty, staff, and students from UA Little Rock rode the Tour de Rock in honor of Steve McClellan’s brother, Bruce.

]]>
UA Little Rock nanotechnology researchers discover new method to quantify graphene at the cellular level /news-archive/2019/02/04/nanotechnology-quantify-graphene/ Mon, 04 Feb 2019 15:19:38 +0000 /news/?p=73294 ... UA Little Rock nanotechnology researchers discover new method to quantify graphene at the cellular level]]> An article written by 91¸£Àû´óÈ« researchers, students, and collaborators has been accepted for publication into “Nanoscale,â€� a peer-reviewed scientific journal, as well as included in the 2018 Nanoscale HOT Article Collection.Ìý The article, “Quantification of cellular associated graphene and induced surface receptor responses,â€� presents a new, combination-based way to quantify and analyze the effect of graphene at the single cell level. The first author, Dr. Zeid A. Nima, is a postdoctoral research fellow at the UA Little Rock Center for Integrative Nanotechnology Sciences (CINS). He received his doctorate in applied chemistry from UA Little Rock in 2014 and joined CINS in 2015. The paper’s additional authors include current and past UA Little Rock students and staff from CINS and the Department of Chemistry, as well as researchers at the University of Arkansas for Medical Sciences, the University of Arkansas, Fayetteville, and the National Center for Toxicological Research. Nima notes that graphene, a nanomaterial, is being used more often in biomedical research and other scientific applications involving humans. However, scientists have generally lacked a way to quantify graphene at the cellular level and assess how cells respond to it. This inability has limited the safe use of graphene in real-world applications. For the past three years, Nima and his collaborators have been developing a solution to the graphene quantification problem. Their new publication represents the result of this work – a method that combines multimodal Raman and photoacoustic/photothermal spectroscopy (UAMS) with a quartz crystal microbalance technique to quantify the amount of graphene in a single cell. “Graphene has been used in nanomedicine and many biological applications, but there have always been challenges in quantifying how much graphene associates with an individual cell,â€� Nima explained. Furthermore, Dr. Bao Vang-Dings, the paper’s second author, studied how human immune cells respond to graphene, based on the amount of and time that cells are exposed to the nanomaterial. “This is important so that we can understand how nanomaterials interact on the cellular level and assess their toxicity to human cells,â€� Nima said. “In the future, this may impact how graphene can be used in applications that affect human health.â€� To read the full article, please visit the. Acknowledgements The research discussed in this article was supported in part by the following sources: U.S. Food and Drug Administration award HHSF223201210189C (administered through the Arkansas Research Alliance). The views presented in this paper are not necessarily those of the U.S. FDA. Partial funding for this work was also provided by the Center for Advanced Surface Engineering, under the National Science Foundation grant IIA-1457888 and the Arkansas Asset III EPSCoR Program.]]> NuShores Biosciences receives $1.7 million grant to study bone regeneration technology /news-archive/2018/09/20/nushores-biosciences-receives-1-7-million-grant-to-study-bone-regeneration-technology/ Thu, 20 Sep 2018 13:10:30 +0000 /news/?p=71913 ... NuShores Biosciences receives $1.7 million grant to study bone regeneration technology]]> A 91¸£Àû´óÈ« spin-off company, has received a $1.7 million grant to study how NuShores’ bone regeneration technology can be applied in craniofacial tissues.Ìý The National Institute of Dental and Craniofacial Research, a component of the National Institutes of Health, has awarded the company a 2.5-year Small Business Innovation Research (SBIR) Fast Track grant to study the NuCressâ„¢ bone filler scaffold’s ability to facilitate dental implants in the jaw. “This NIH award is a direct result of the profound study results in long bone delivered by our research collaborators at UA Little Rock and the University of Tennessee College of Veterinary Medicine. The reviewers were able to clearly see the potential in dental applications for this technology. I’m excited to work with world-class clinicians to study the NuCressâ„¢ scaffold for the future benefit of their patients,â€� states Sharon Ballard, NuShores’ CEO. The NuCressâ„¢ scaffold is a nanomaterial-based bone regeneration device developed for large segmental defects. This development is led by Dr. Alex Biris, the director and chief scientist of the UA Little Rock Center for Integrative Nanotechnology Sciences and a professor of systems engineering in the Donaghey College of Engineering and Information Technology. “This is a significant win to expand NuShores’ technology, made possible through our university relationships, Arkansas’ small business development infrastructure, and tireless work by a dedicated team. We are grateful,â€� said Biris.
NuShores Biosciences, LLC

NuShores Biosciences, LLC

NuShores has partnered with Stony Brook University School of Dental Medicine on this grant. If successful, the scaffold will be a transformational tool for surgeons involved in bone regeneration in a variety of fields. Founded in 2014, NuShores has the exclusive, global license from UA Little Rock to commercialize university-owned patented and patent-pending technologies related to the NuCress™ scaffold. The company has received assistance from the Arkansas Small Business and Technology Development Center. The NuCress™ scaffold has already given a number of animals a new lease on life. For example, just last year, it was used at the University of Tennessee College of Veterinary Medicine to heal Hercules, an alpaca who broke his leg on his ranch in Lebanon, Tennessee, at only 24 hours old. The open wound and exposed bone led to a serious infection, which prevented the bone from healing properly. Against the odds, the scaffold eliminated the infection and completely regenerated the missing bone. Thanks to the NuCress™ scaffold, Hercules is now a thriving member of his herd. About the SBIR Program The SBIR program involves 11 federal agencies investing more than $3 billion a year in high risk/high payoff research and development conducted by the nation’s leading science-technology innovators. NuShores’ award is known as a Fast Track Grant, where funding occurs when SBIR Phase I and Phase II proposals are peer reviewed at the same time and granted in a single award. This approach expedites funding and research for the companies. Research described in this press release is supported by the National Center for Dental and Craniofacial Research of the National Institutes of Health under award number 1R44DE028213-01.]]>
UA Little Rock Cycling Club members ride Tour de Rock in honor of vice chancellor’s brother /news-archive/2018/06/20/cycling-club-steve-mcclellan/ Wed, 20 Jun 2018 13:32:58 +0000 /news/?p=70803 ... UA Little Rock Cycling Club members ride Tour de Rock in honor of vice chancellor’s brother]]> Steve McClellan, vice chancellor for finance and administration at the 91¸£Àû´óÈ«, wanted to do something to support his brother.Ìý Bruce McClellan, who lives near Alexandria, Louisiana, was diagnosed with lung cancer last year and has been fighting the disease ever since. “My brother found out that he had a pretty serious situation going on with cancer,â€� McClellan said. “There is not much I can do other than support him. Sometimes, you want to do whatever you can to let the person know that you are there.â€� His attention turned to CARTI’s 15th annual Tour de Rock on June 2. McClellan and his family members have often participated in the cycling fundraiser that supports CARTI’s continued fight against cancer by providing the most advanced forms of treatment available while also meeting the needs of patients and their families. McClellan sponsored a team of 12 UA Little Rock riders who participated in the Tour de Rock in honor of Bruce. McClellan and his wife, Ladye Ann, also rode in the event. He contacted Martial Trigeaud, business consultant with the Arkansas Small Business and Technology Development Center and one of the faculty advisors of the UA Little Rock Cycling Club, who immediately put the call out on social media for club members who would be interested in riding in the Tour de Rock. “I said I was sure we could find people to ride for them,â€� Trigeaud said. “I posted it on Facebook. In less than five minutes, I had 10 people reaching out to me to say they wanted to ride for Steve McClellan and his brother. Many of the members were excited to ride in honor of Bruce and members of their family who were affected by cancer.â€�Ìý
Layde Ann and Steve McClellan ride the Tour de Rock to raise money for CARTI in honor of Steve's brother, Bruce.

Layde Ann and Steve McClellan ride the Tour de Rock to raise money for CARTI in honor of Steve’s brother, Bruce.

UA Little Rock employees and students who rode in the Tour de Rock include Alex Biris, director of the Center for Integrative Nanotechnology Sciences; Thomas Bunton of Information Technology Services; Emilie Darrigues, a Ph.D. student of applied science; John Evans, associate athletics director for facilities and events; Ian Hadden, director of energy management services; Luis Lopez; a student majoring in political science; Matthew Morton of the Department of Public Safety; Melanie Ridlon, a student in the MBA program; and Drew Smith, an adjunct instructor for the Nonprofit Leadership Studies Program. Unfortunately, Trigeaud, who was meant to be the 10th UA Little Rock rider, could not participate due to an injury. Cyclists choose to ride distances of 25, 50, 62, 80, or 100 miles. The UA Little Rock team members rode nearly 500 miles in honor of Bruce McClellan. Altogether, 880 riders participated in Tour de Rock, including riders from Illinois, Massachusetts, Minnesota, Missouri, Mississippi, Oklahoma, Pennsylvania, Tennessee, and Texas. “They put together a very diverse team of riders in a very short period of time, which I thought was remarkable. I’m thankful to Martial Trigeaud and Ian Hadden for putting that together,â€� McClellan said. “My brother was real proud and very thankful. He is a very religious person, so the ride meant a lot to him. A lot of riders sent me thank you notes, and I forwarded all those to my brother.â€� In the upper right photo,Ìý91¸£Àû´óÈ« employees and students ride the Tour de Rock to raise money for CARTI in honor of Steve McClellan’s brother, Bruce.Ìý]]>